External limiting membrane: retinal structural barrier in diabetic macular edema
Authors:
Open Access
- 4 March 2021
- journal article
- editorial
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 7 (1) , 1-3
Abstract
Advances in spectral-domain optical coherence tomography (SD-OCT) technology have enhanced the understanding of external limiting membrane (ELM) and ellipsoid zone (EZ) in diabetic macular edema. An increase in VEGF has been demonstrated to be associated with sequential ELM and EZ disruption on SD-OCT. An intact ELM is a prerequisite for an intact EZ in DME. Anti-VEGF therapy leads to restoration of barrier effect of ELM. The ELM restores first followed by EZ restoration.Keywords
This publication has 31 references indexed in Scilit:
- Association between external limiting membrane status and visual acuity in diabetic macular oedemaBritish Journal of Ophthalmology, 2012
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Biological activity is the likely origin of the intersection between the photoreceptor inner and outer segments of the rat retina as determined by optical coherence tomographyClinical Ophthalmology, 2011
- The Photoreceptor Layer As a Prognostic Factor for Visual Acuity in the Secondary Epiretinal Membrane After Retinal Detachment Surgery: Imaging Analysis By Spectral-Domain Optical Coherence TomographyAmerican Journal of Ophthalmology, 2011
- The outer limiting membrane (OLM) revisited: clinical implicationsClinical Ophthalmology, 2010
- Phagocytosis of Retinal Rod and Cone PhotoreceptorsPhysiology, 2010
- Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced PermeabilityJournal of Biological Chemistry, 2009
- Characterization of Outer Retinal Morphology with High-Speed, Ultrahigh-Resolution Optical Coherence TomographyInvestigative Ophthalmology & Visual Science, 2008
- INTRAVITREAL BEVACIZUMAB INJECTIONS FOR TREATMENT OF CENTRAL RETINAL VEIN OCCLUSIONRetina, 2007
- The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?Eye, 2002